Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1985 1
1988 1
1994 1
1996 1
2002 1
2003 1
2005 1
2006 1
2008 2
2009 1
2010 2
2011 1
2012 1
2014 1
2015 2
2016 1
2018 1
2019 3
2020 7
2021 7
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Managing low back pain in active adolescents.
O'Sullivan K, O'Keeffe M, Forster BB, Qamar SR, van der Westhuizen A, O'Sullivan PB. O'Sullivan K, et al. Among authors: van der westhuizen a. Best Pract Res Clin Rheumatol. 2019 Feb;33(1):102-121. doi: 10.1016/j.berh.2019.02.005. Epub 2019 Feb 23. Best Pract Res Clin Rheumatol. 2019. PMID: 31431266 Review.
Targeting DNA Repair in Ovarian Cancer Treatment Resistance.
Wong-Brown MW, van der Westhuizen A, Bowden NA. Wong-Brown MW, et al. Among authors: van der westhuizen a. Clin Oncol (R Coll Radiol). 2020 Aug;32(8):518-526. doi: 10.1016/j.clon.2020.03.005. Epub 2020 Apr 3. Clin Oncol (R Coll Radiol). 2020. PMID: 32253106 Review.
Mimicking Meningismus: A Case of Atlantoaxial Gout.
Gorman J, Van Der Westhuizen A, Raheez Qamar S, Funnell C. Gorman J, et al. Among authors: van der westhuizen a. Neurol Clin Pract. 2021 Jun;11(3):e353-e355. doi: 10.1212/CPJ.0000000000001053. Neurol Clin Pract. 2021. PMID: 34484912 Free PMC article. No abstract available.
Metastatic melanoma treatment: Combining old and new therapies.
Davey RJ, van der Westhuizen A, Bowden NA. Davey RJ, et al. Among authors: van der westhuizen a. Crit Rev Oncol Hematol. 2016 Feb;98:242-53. doi: 10.1016/j.critrevonc.2015.11.011. Epub 2015 Nov 17. Crit Rev Oncol Hematol. 2016. PMID: 26616525 Review.
How anti-PD1 treatments are changing the management of melanoma.
Hersey P, Kakavand H, Wilmott J, van der Westhuizen A, Gallagher S, Gowrishankar K, Scolyer R. Hersey P, et al. Among authors: van der westhuizen a. Melanoma Manag. 2014 Nov;1(2):165-172. doi: 10.2217/mmt.14.14. Epub 2014 Dec 4. Melanoma Manag. 2014. PMID: 30190821 Free PMC article. Review.
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
Bhave P, Pallan L, Long GV, Menzies AM, Atkinson V, Cohen JV, Sullivan RJ, Chiarion-Sileni V, Nyakas M, Kahler K, Hauschild A, Plummer R, Trojaniello C, Ascierto PA, Zimmer L, Schadendorf D, Allayous C, Lebbe C, Maurichi A, Santinami M, Roy S, Robert C, Lesimple T, Patel S, Versluis JM, Blank CU, Khattak A, Van der Westhuizen A, Carlino MS, Shackleton M, Haydon A. Bhave P, et al. Among authors: van der westhuizen a. Br J Cancer. 2021 Feb;124(3):574-580. doi: 10.1038/s41416-020-01121-y. Epub 2020 Oct 22. Br J Cancer. 2021. PMID: 33087895 Free PMC article.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Bendell JC, Sauri T, Gracián AC, Alvarez R, López-López C, García-Alfonso P, Hussein M, Miron ML, Cervantes A, Montagut C, Vivas CS, Bessudo A, Plezia P, Moons V, Andel J, Bennouna J, van der Westhuizen A, Samuel L, Rossomanno S, Boetsch C, Lahr A, Franjkovic I, Heil F, Lechner K, Krieter O, Hurwitz H; McCAVE Study Group. Bendell JC, et al. Among authors: van der westhuizen a. Oncologist. 2020 Mar;25(3):e451-e459. doi: 10.1634/theoncologist.2019-0291. Epub 2019 Sep 30. Oncologist. 2020. PMID: 32162804 Free PMC article. Clinical Trial.
38 results